946 related articles for article (PubMed ID: 16831265)
41. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
[TBL] [Abstract][Full Text] [Related]
42. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
Tong JH; Tsang RK; Lo KW; Woo JK; Kwong J; Chan MW; Chang AR; van Hasselt CA; Huang DP; To KF
Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892
[TBL] [Abstract][Full Text] [Related]
43. Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort.
Sun XS; Chen WH; Liu SL; Liang YJ; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Li XY; Yan JJ; Mai HQ; Tang LQ
Cancer Med; 2019 Aug; 8(9):4214-4225. PubMed ID: 31210417
[TBL] [Abstract][Full Text] [Related]
44. Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival.
Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Tsai CS; Wei YH
J Clin Oncol; 2001 May; 19(10):2607-15. PubMed ID: 11352952
[TBL] [Abstract][Full Text] [Related]
45. Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma.
Wang WY; Twu CW; Chen HH; Jan JS; Jiang RS; Chao JY; Liang KL; Chen KW; Wu CT; Lin JC
Clin Cancer Res; 2010 Feb; 16(3):1016-24. PubMed ID: 20103659
[TBL] [Abstract][Full Text] [Related]
46. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.
Lo YM; Chan AT; Chan LY; Leung SF; Lam CW; Huang DP; Johnson PJ
Cancer Res; 2000 Dec; 60(24):6878-81. PubMed ID: 11156384
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
Chua DT; Nicholls JM; Sham JS; Au GK
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
[TBL] [Abstract][Full Text] [Related]
48. Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma.
Chen WH; Tang LQ; Zhang L; Chen QY; Guo SS; Liu LT; Fan W; Zhang X; Guo L; Zhao C; Cao KJ; Qian CN; Guo X; Xie D; Zeng MS; Mai HQ
Oncotarget; 2015 Nov; 6(35):38296-307. PubMed ID: 26512922
[TBL] [Abstract][Full Text] [Related]
49. Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels.
Wang WY; Twu CW; Chen HH; Jiang RS; Wu CT; Liang KL; Shih YT; Chen CC; Lin PJ; Liu YC; Lin JC
Cancer; 2013 Mar; 119(5):963-70. PubMed ID: 23065693
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract][Full Text] [Related]
51. Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma.
Hsu CL; Chang KP; Lin CY; Chang HK; Wang CH; Lin TL; Liao CT; Tsang NM; Lee LY; Chan SC; Ng SH; Li HP; Chang YS; Wang HM
Head Neck; 2012 Aug; 34(8):1064-70. PubMed ID: 22083949
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
Mutirangura A; Pornthanakasem W; Theamboonlers A; Sriuranpong V; Lertsanguansinchi P; Yenrudi S; Voravud N; Supiyaphun P; Poovorawan Y
Clin Cancer Res; 1998 Mar; 4(3):665-9. PubMed ID: 9533535
[TBL] [Abstract][Full Text] [Related]
53. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years.
Polychronopoulou S; Kostaridou S; Panagiotou JP; Stefanaki K; Papadakis V; Florentin L; Houlakis M; Christopoulos G; Haidas S
Pediatr Hematol Oncol; 2004; 21(5):393-402. PubMed ID: 15205082
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.
Chen WH; Tang LQ; Guo SS; Chen QY; Zhang L; Liu LT; Qian CN; Guo X; Xie D; Zeng MS; Mai HQ
Medicine (Baltimore); 2016 Feb; 95(5):e2642. PubMed ID: 26844482
[TBL] [Abstract][Full Text] [Related]
55. [Impact of pre-radiotherapy hemoglobin level on local control of nasopharyngeal carcinoma].
Mai HQ; Mo HY; Hong MH; Guo X; Deng MQ; Zhang F; Min HQ
Ai Zheng; 2005 Jun; 24(6):727-30. PubMed ID: 15946489
[TBL] [Abstract][Full Text] [Related]
56. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
Tang LQ; Chen QY; Fan W; Liu H; Zhang L; Guo L; Luo DH; Huang PY; Zhang X; Lin XP; Mo YX; Liu LZ; Mo HY; Li J; Zou RH; Cao Y; Xiang YQ; Qiu F; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Mai HQ
J Clin Oncol; 2013 Aug; 31(23):2861-9. PubMed ID: 23857969
[TBL] [Abstract][Full Text] [Related]
57. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
Guo ZM; Liu WW; He JH
Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
[TBL] [Abstract][Full Text] [Related]
58. [Real-time quantitative PCR assay of Epstein-Barr virus in whole blood cells of nasopharyngeal carcinoma patients].
Wang H; Deng L; Chen SH; Wang SQ; Cao Y
Shi Yan Sheng Wu Xue Bao; 2003 Feb; 36(1):32-6. PubMed ID: 12751207
[TBL] [Abstract][Full Text] [Related]
59. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
60. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]